Cargando…
Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends
Glioblastoma (GBM) is a highly aggressive disease and is associated with poor prognosis despite treatment advances in recent years. Surgical resection of tumor remains the main therapeutic option when approaching these patients, especially when combined with adjuvant radiochemotherapy. In the presen...
Autores principales: | Sales, Arthur H. A., Beck, Jürgen, Schnell, Oliver, Fung, Christian, Meyer, Bernhard, Gempt, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505564/ https://www.ncbi.nlm.nih.gov/pubmed/36143001 http://dx.doi.org/10.3390/jcm11185354 |
Ejemplares similares
-
Chronotherapy in Glioblastoma: State of the art and future perspectives
por: Petković, Marina, et al.
Publicado: (2023) -
Glioblastoma Treatment: State-of-the-Art and Future Perspectives
por: Rodríguez-Camacho, Alejandro, et al.
Publicado: (2022) -
Glioblastoma: State of the Art and Future Perspectives
por: Tabatabai, Ghazaleh, et al.
Publicado: (2019) -
Glioblastoma multiforme: State of the art and future therapeutics
por: Wilson, Taylor A., et al.
Publicado: (2014) -
High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients
por: Hönikl, Lisa Stefanie, et al.
Publicado: (2020)